We found that PIK3CAAmp/TP53Mutated HNSCC patients who expressed a higher level of VEGF-C or both CSF1 and VEGF-C exhibited worse survival (Fig. 5E). The gene discussed is CSF1; the disease is head and neck squamous cell carcinoma.